Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB19178InvestigationalSmall molecule
OSU-6162 is under investigation in clinical trial NCT05641623 (OSU6162 as Add-on in Ssri/snri-resistant Depression).
- Mechanism
- Curator reviewed
Pharmacologically active on Dopamine receptor D2
- Formula / weight
- C15H23NO2S · 281.41 g/mol (avg)
- Code names
- (-)-OSU 6162 · PNU-96391
Resolves to
Structure
InChIKey
GZVBVBMMNFIXGE-CQSZACIVSA-NSMILESCCCN1CCC[C@H](C1)C1=CC=CC(=C1)S(C)(=O)=OTargets
What you can answer from here — as of July 09, 2026
Which drugs share a target with OSU-6162, and which of those have an active Phase 3 trial?